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Twenty-Five Year Secular Trends in Lipids and Modiﬁable Risk Factors
in a Population-Based Biracial Cohort: The Coronary Artery Risk
Development in Young Adults (CARDIA) Study, 1985–2011
Pamela J. Schreiner, PhD; David R. Jacobs Jr, PhD; Nathan D. Wong, PhD; Catarina I. Kiefe, MD, PhD
Background-—Cross-sectional analyses suggest that total and low-density lipoprotein cholesterol (LDL-c) trends that had been
declining are now reversing. We examined longitudinal data from the Coronary Artery Risk Development in Young Adults (CARDIA)
study to examine secular trends in total cholesterol, LDL-c, high-density lipoprotein cholesterol (HDL-c), and triglycerides over
25 years. We also assessed whether modiﬁable lifestyle factors (body mass index, physical activity, alcohol consumption, smoking,
and lipid-lowering medications) are associated with these trends.
Methods and Results-—CARDIA recruited 5115 black and white men and women ages 18 to 30 years from 4 US communities in
1985–1986, and re-examined them 5, 10, 15, 20, and 25 years later. Secular trends, modeled as age-matched time trends, were
estimated using repeated-measures regression stratiﬁed on race and sex. Total cholesterol and LDL-c initially decreased 5 to
8 mg/dL between visits before plateauing and moving toward adverse trends in all groups, except black women, by year 25. HDL-c
showed an upward secular trend of 1 to 3 mg/dL between visits starting at year 15 in all groups; triglyceride trends were largely
ﬂat. Obesity and use of lipid-lowering medications, which both increased over follow-up, had strong independent, but opposite,
associations with lipid trends over time. In aggregate, associations of modiﬁable lifestyle factors counterbalanced one another,
minimally inﬂuencing secular trends.
Conclusions-—Over 25 years, initially favorable trends in total cholesterol and LDL-c have leveled off and may be reversing,
persisting after control for modiﬁable risk factors. Factors such as dietary changes over 25 years and poor adherence to
medications are candidates for additional investigation. ( J Am Heart Assoc. 2016;5:e003384 doi: 10.1161/JAHA.116.003384)
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E levated levels of total cholesterol, low-density lipopro-tein cholesterol (LDL-c), and triglycerides and low levels
of high-density lipoprotein cholesterol (HDL-c) have been
linked with cardiovascular disease morbidity and mortality in
numerous population-based and clinical studies.1–4 Individu-
als with elevated lipid values have high relative risk of future
cardiovascular events and often beneﬁt from antihyperlipi-
demic medication therapy. Individuals with only mildly
elevated lipid levels have lower relative risks, but comprise
the majority of abnormal values; these individuals may
respond to lifestyle modiﬁcation and therefore offer opportu-
nities for primary prevention.
Secular trend data based on serial cross-sectional data
from the National Health and Nutrition Examination Survey
(NHANES) have suggested that total and LDL-c levels have
declined in most race/ethnic and sex groups over the past
20 years.5 These favorable trends in total and LDL-c have
been replicated in many Western countries during the same
time period, whereas trends in HDL-c and triglycerides have
exhibited less-consistent patterns. A recent report by Carroll
et al.,6 extending NHANES data through 2010, suggests that
favorable trends continue among most subgroups, regardless
of lipid-lowering medication status. Other serial cross-
sectional data suggest that the favorable secular trends have
either ﬂattened out or are reversing.7–9
However, longitudinal data, as opposed to serial cross-
sectional data, allow for a better understanding of the effects
of both time and aging while accounting for changes in
potential correlates, such as obesity on lipid proﬁles. Given
the strong association of adverse lipid levels with
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cardiovascular disease morbidity and mortality, we used data
from the community-based Coronary Artery Risk Development
in Young Adults (CARDIA) study to examine secular and aging
trends in total cholesterol, LDL-c, HDL-c, and triglycerides
over 25 years of follow-up in a ﬁxed biracial cohort of men
and women who were 18 to 30 years old at baseline. We also
assessed whether the observed lipid trends were confounded
by modiﬁable risk factors—body mass index (BMI), physical
activity, ethanol consumption, and smoking—after controlling
for age, education, and study center. Our goal was to identify
risk factors that may have attenuated observed favorable lipid
trends or contributed to adverse lipid trends in a cohort that
has moved from young adulthood to middle age during the
obesity epidemic.
Methods
Study Population
Participants for this study were from the CARDIA study, a
multicenter, longitudinal study of the development of cardio-
vascular risk factors in black and white adults ages 18 to
30 years in 1985–1986 recruited from 4 US cities: Birming-
ham, Alabama; Chicago, Illinois; Minneapolis, Minnesota; and
Oakland, California. The CARDIA study cohort included 5115
participants free of cardiovascular disease at baseline
recruited to be balanced within each center on race, sex,
age, and education.10 Follow-up examinations were con-
ducted 2, 5, 7, 10, 15, 20, and 25 years after baseline with
response rates of 91%, 86%, 81%, 79%, 74%, 72%, and 72% of
the surviving cohort, respectively. Data for the current study
are based on participants attending examinations that were
5 years apart: year 0 (baseline), year 5, year 10, year 15, year
20, and year 25 examinations. The CARDIA study was
approved by the institutional review boards of the coordinat-
ing center and the 4 participating ﬁeld centers, and written
informed consent was obtained from participants at all
examinations.
Measurements
Age and race were self-reported using standardized question-
naires, as were years of education completed, use of
cholesterol-lowering medication, smoking status (current,
former, or never), and ethanol consumption in milliliters per
day based on the quantity and type of alcoholic beverages
consumed. BMI was calculated as weight in kilograms divided
by height in meters squared. Physical activity was estimated
from an interviewer-administered questionnaire based on the
amount of moderate and heavy physical activity performed
during the past year11—a score of 300 exercise units (EU) is
roughly equivalent to 150 minutes of moderate physical
activity per week, or ﬁve 30-minute sessions.12 Diet was only
assessed at years 0, 7, and 20 in CARDIA, with saturated fat
intake and total caloric intake derived from an interviewer-
administered diet history questionnaire developed for the
CARDIA study.13
All participants were asked to fast for 12 hours before
each clinic visit. Serum and plasma blood samples were
drawn from the antecubital vein and stored at 70°C until
analyzed. Plasma total cholesterol, HDL-c, and triglyceride
levels were measured using enzymatic methods14; HDL-c
levels were measured after dextran-sulfate-magnesium pre-
cipitation of other lipoproteins.15 LDL-c levels were estimated
with the Friedewald equation for individuals with fasting
triglyceride values less than 400 mg/dL.16 Extensive quality
control has been implemented by CARDIA to reduce variability
in longitudinal laboratory data; the test-retest correlation for
total cholesterol, HDL-c, LDL-c, and triglycerides was 0.98 to
0.99.17
Statistical Analyses
Means and frequencies of covariates of interest were
obtained at time points modeled as class variables corre-
sponding with clinic visits conducted 5 years apart—years 0,
5, 10, 15, 20, and 25. Repeated-measures regression was
performed on ﬁxed effects models using a Toeplitz covariance
structure and stratiﬁed by race and sex. Whereas the age
ranges across all 6 exams considered here do not completely
overlap, sensitivity analyses showed little difference when
analyses were limited to subsamples with overlapping age
ranges longitudinally; therefore, we retained the 5-year
interval approach. All available data were included at each
time point under the assumption that missing data were
missing at random.
Mean secular trends in lipids were generated by adjusting
crude values at each time point with age. Speciﬁcally, time
was modeled as a class variable and current age was modeled
continuously using a quadratic ﬁt. We assumed no birth
cohort effect given the narrow age range of the cohort. By
treating time as a homogenous variable at each clinic visit and
age continuously, the period and age effects are algebraically
separated. Therefore, the period effect was considered an
age-matched time trend, comparing mean levels in groups of
people who achieved a given age at 1 calendar time to the
mean levels in groups who achieved the same age at a
different calendar time. The period effect was then modeled
as a calendar time trend in these age-matched values.18
Multivariable longitudinal models were further adjusted for
clinic site, education, BMI, physical activity, smoking status,
amount of alcohol consumed, and antihyperlipidemic medi-
cation use. Though these covariates were included at each
categorical time point, interactions of covariates with time
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were not consistently statistically signiﬁcantly associated with
different lipid outcomes. Therefore, all covariate adjustment in
these models represents pooled averages across time. When
we included dietary saturated fat and total caloric intake in
additional multivariable-adjusted models to assess confound-
ing of the secular trend data, we observed no changes in
secular trends in lipids by these dietary factors. We therefore
chose not to include diet in our analyses.
Interactions of time with race and sex were examined as
additive interaction terms based on differences we observed
in mean levels of lipids for these groups. Both interactions
were statistically signiﬁcant for all lipid outcomes, so we
consequently presented analyses stratiﬁed by both race and
sex. All analyses were 2-sided with a type 1 error of 0.05
considered as statistically signiﬁcant. Analyses were con-
ducted using SAS software (v.9.3; SAS Institute, Inc., Cary,
NC).
Results
Table 1 shows means and frequencies of population demo-
graphics across time. Mean age at year 0 was 24.8 years and
increased to 50.2 years at year 25. Mean BMI increased over
time from 24.5 to 30.2 kg/m2; educational attainment
increased as well. Physical activity decreased with time, and
prevalence of current smoking also was less common at year
25 compared to year 0, decreasing from 30.4% to 17.1%.
Alcohol use decreased from year 0 to year 5 and then
remained relatively stable through year 25. White participants
and women were slightly more likely to attend exams after
year 0. Use of antihyperlipidemic medications also increased
over time in all race-sex groups, with no reported use of these
medications at baseline when the cohort was ages 18 to
30 years and between 10% and 20% using these medications
by year 25. Men were more likely to be using lipid-lowering
medications, with white men reporting the highest use by year
25 (20.0%).
Unadjusted mean lipid values across follow-up are pre-
sented stratiﬁed by race and sex in Figure 1. Total cholesterol
tended to increase in all groups, whereas triglycerides
consistently increased in all race and sex groups with some
evidence of plateauing by year 25, and LDL-c remained
relatively constant across time. HDL-c also exhibited a mostly
ﬂat trend across time, with all 4 race-sex groups showing an
increase in years 20 and 25 that exceeded baseline values.
Secular trends—time trends adjusted for aging—for lipids
are presented by race and sex in Figure 2. Compared to the
unadjusted means presented in Figure 1, secular trends in
total cholesterol decreased over the 25 years of follow-up,
largely in the period from 1985 to 1995 (year 0 to year 10),
with the suggestion of an upward trend between years 20 and
25 in all except black women. Similar trends were observed
for LDL-c. Controlling for age had little effect on HDL-c trends,
whereas the increasing mean triglyceride trends observed in
the crude data were attenuated with control for age,
particularly among blacks; whites, particularly women, exhib-
Table 1. Means (SD) and Frequencies of Selected Demographic Characteristics Over 25 Years of Follow-up: the CARDIA Study,
1985–2011
Year 0 Year 5 Year 10 Year 15 Year 20 Year 25
N (range)* 5034 to 5115 4302 to 4352 3838 to 3944 3605 to 3672 3467 to 3549 3478 to 3497
Age, y 24.83.7 30.03.6 35.03.7 40.23.6 45.23.6 50.23.6
BMI, kg/m2 24.55.0 26.15.9 27.56.5 28.86.8 29.47.0 30.27.2
Education, yr 13.82.3 14.42.4 14.73.2 14.92.5 15.02.6 15.12.7
Physical activity (EU) 420.2300.7 379.4292.5 331.0275.0 347.3283.6 335.9274.1 337.9275.7
Alcohol, mL/day 12.121.9 11.225.6 10.922.1 11.024.9 10.822.2 11.723.4
Current smokers (%) 30.4 28.6 25.6 22.0 19.4 17.1
Former smokers (%) 13.3 14.1 16.5 18.1 19.4 21.8
White (%) 48.5 51.3 51.3 52.9 53.5 53.1
Men (%) 45.5 45.0 44.5 44.1 43.3 43.4
Lipid-lowering medication use (%)
Black men 0 0 0.5 2.4 8.5 15.6
Black women 0 0.2 0.2 1.4 7.7 17.2
White men 0 0.4 0.6 4.8 15.0 20.0
White women 0 0.4 0.7 1.3 4.9 10.4
*N varies because of small numbers of missing values for the demographic data. BMI indicates body mass index; EU, exercise units.
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ited increasing trends in triglycerides for both crude and age-
adjusted models.
Table 2 shows mean changes in lipids for men by race in 5-
year intervals from baseline after controlling for age, educa-
tion, and clinic site (model 1) and modiﬁable lifestyle factors
(model 2). Multivariable-adjusted secular trends differed by
race (P interaction <0.05 for time9race for all lipids; results
not shown). LDL-c decreased across most time periods, from
7.3 mg/dL in black men between years 0 and 5 to
0.67 mg/dL in white men between years 20 and 25, with
smaller decreases in white men compared to black men,
consistent with the age-adjusted trends shown in Figure 2.
The decline in LDL-c ended after year 20, with no statistically
signiﬁcant differences between years 20 and 25 for either
race group.
Whereas other risk factors, such as smoking status, were
inconsistently associated with LDL-c in each race group, BMI
was one of the strongest predictors of increases in LDL-c
levels independent of secular trend. Obesity, here modeled as
BMI ≥30 kg/m2 pooled across time, was associated with a
7.74-mg/dL increase in LDL-c over 25 years among black
men and a 2.41-mg/dL increase among white men compared
to being overweight or normal weight. Use of antihyperlipi-
demic medications was associated with large decreases in
mean LDL-c over time; however, after including medications
and modiﬁable lifestyle factors, the secular trends changed
minimally, as reﬂected in the modest differences in the point
estimates for the 5-year changes in lipids between models 1
and 2. In aggregate, the positive and inverse associations of
the modiﬁable lifestyle factors examined counterbalanced
each other, leading to the modest changes described above.
Total cholesterol mirrored the trends observed for LDL-c.
Declines in HDL-c levels were observed early in follow-up
with increases in the later examination years, reﬂecting the
nonlinear patterns observed in the crude and age-adjusted
ﬁgures. After controlling for lifestyle and demographic factors,
the HDL-c trends across time were not uniformly statistically
signiﬁcant in either race group but reﬂected the trends
observed in model 1. Similar to the LDL-c and total
cholesterol ﬁndings, the risk factor most strongly associated
Figure 1. Unadjusted mean plasma lipid values by race and sex across 25 years of follow-up: the CARDIA study, 1985–2011. BM indicates
black men; BW, black women; CARDIA, Coronary Artery Risk Development in Young Adults; HDL-c, high-density lipoprotein cholesterol; LDL-c,
low-density lipoprotein cholesterol; WM, white men; WW, white women.
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with HDL-c levels was obesity, accounting for 5.5 and
4.6 mg/dL over 25 years in black men and white men,
respectively. Despite these strong independent associations
of obesity with HDL-c levels, the secular changes between
examinations were minimally altered by modiﬁable lifestyle
factors, as observed for total cholesterol and LDL-c. In
addition, antihyperlipidemic medication use was not statisti-
cally signiﬁcantly associated with HDL-c in men.
Unlike the other three lipids, triglycerides displayed
essentially no secular trends in black men and white men
before or after adding modiﬁable risk factors to the models.
Obesity again was associated with the largest increases in
triglycerides relative to nonobese participants, accounting for
increases over 25 years of 29.3 mg/dL in black men and
45.8 mg/dL in white men. Physical activity, modeled as at or
above the sex-speciﬁc 75th percentile compared with below
the 75th percentile, was modestly and inversely associated
with mean triglyceride levels over time, with a decrease of
5.2 mg/dL in black men and 9.1 mg/dL in white men.
Current smoking status pooled over 25 years was associated
with 6.2 and 12.1 mg/dL higher triglycerides compared to
never smokers in black and white men, respectively.
Table 3 repeats the analyses presented in Table 2 for
women. As with men, the interactions of time9race were
statistically signiﬁcant for all lipids. The largest mean LDL-c
decreases were observed in black women, and obesity was
strongly associated with LDL-c trends for both race groups (a
7.24 mg/dL increase among black women and a 9.61 mg/dL
increase among white women). Total cholesterol trends were
similar to LDL-c trends.
Consistent with men, HDL-c trends for women in both race
groups were nonlinear, increasing in the later years of follow-
up to 2.97 and 2.39 mg/dL in black women and white
women, respectively, between years 20 and 25. Physical
activity was associated with modest, but statistically signif-
icantly higher, HDL-c as was observed in men; however,
current cigarette smoking was associated with lower HDL-c
levels in women only. Once again, obesity accounted for large
declines in HDL-c: 6.8 and 8.4 mg/dL decreases over
25 years in black women and white women, respectively.
Figure 2. Secular trends in mean plasma lipid values by race and sex across 25 years of follow-up after adjusting for age (age+age2): the
CARDIA study, 1985–2011. BM indicates black men; BW, black women; CARDIA, Coronary Artery Risk Development in Young Adults; HDL-c,
high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; WM, white men; WW, white women.
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Table 2. Changes in Plasma Lipid Levels (in mg/dL) Among Men in 5-Year Intervals Over 25 Years of Follow-up, Adjusted for Age,
Education, and Clinic Site (Model 1) Plus Modiﬁable Lifestyle Factors (Model 2), by Race Group: the CARDIA Study, 1985–2011
Black Men/Model 1 Black Men/Model 2 White Men/Model 1 White Men/Model 2
LDL-c
CARDIA exams
Year 5 to Year 0 6.54 (9.34, 3.73)* 7.30 (10.09, 4.51)* 5.53 (8.23, 2.83)* 5.44 (8.16, 2.71)*
Year 10 to Year 5 3.23 (0.25, 6.21)* 4.13 (7.06, 1.20)* 3.95 (6.82, 1.09)* 4.68 (7.49, 1.88)*
Year 15 to Year 10 0.14 (2.95, 3.22) 1.22 (4.25, 1.80) 2.60 (0.30, 5.51) 2.63 (0.22, 5.47)
Year 20 to Year 15 6.35 (3.12, 9.57)* 6.08 (9.25, 2.90)* 6.58 (9.56, 3.59)* 4.83 (7.75, 1.91)*
Year 25 to Year 20 1.71 (1.63, 5.05) 1.49 (1.77, 4.76) 2.12 (1.00, 5.25) 0.67 (2.35, 3.69)
BMI (≥30 vs <30 kg/m2) 7.74 (5.67, 9.81)* 2.41 (0.37, 4.46)*
Physical activity
(≥75th percentile
vs <75th percentile)†
0.73 (2.32, 0.86) 1.48 (2.98, 0.020)
Current vs never smokers 7.64 (10.08, 5.19)* 2.62 (0.11, 5.36)
Former vs never smokers 2.84 (5.63, 0.048)* 0.44 (2.03, 2.91)
Alcohol (yes/no) 1.74 (3.36, 0.11)* 0.026 (1.56, 1.61)
Antihyperlipidemic
medications (yes/no)
31.0 (34.6, 27.4)* 44.2 (47.0, 41.5)*
HDL-c
CARDIA exams
Year 5 to Year 0 1.84 (3.06, 0.62)* 1.15 (0.025, 2.32) 1.38 (2.40, 0.37)* 1.03 (2.01, 0.045)*
Year 10 to Year 5 3.93 (5.18, 2.67)* 3.33 (4.55, 2.11)* 3.82 (4.85, 2.78)* 3.59 (4.59, 2.60)*
Year 15 to Year 10 1.48 (2.78, 0.18)* 0.89 (2.15, 0.37) 1.09 (2.13, 0.043)* 0.81 (1.82, 0.19)
Year 20 to Year 15 1.94 (0.57, 3.30)* 2.20 (0.87, 3.52)* 1.51 (0.45, 2.58)* 1.70 (0.67, 2.73)*
Year 25 to Year 20 2.72 (1.31, 4.13)* 2.89 (1.52, 4.26)* 2.45 (1.35, 3.54)* 2.71 (1.65, 3.77)*
BMI (≥30 vs <30 kg/m2) 5.53 (6.42, 4.65)* 4.64 (5.33, 3.95)*
Physical activity
(≥75th percentile vs
<75th percentile)†
1.00 (0.30, 1.69)* 1.42 (0.92, 1.93)*
Current vs never smokers 0.23 (0.81, 1.27) 2.41 (3.37, 1.46)*
Former vs never smokers 0.91 (2.12, 0.29) 0.35 (1.20, 0.50)
Alcohol (yes/no) 4.10 (3.39, 4.80)* 3.01 (2.48, 3.55)*
Antihyperlipidemic
medications (yes/no)
0.052 (1.61, 1.51) 0.47 (0.45, 1.38)
Total cholesterol
CARDIA exams
Year 5 to Year 0 7.35 (10.40, 4.31)* 7.71 (10.77, 4.65)* 5.82 (8.85, 2.80)* 5.70 (8.75, 2.66)*
Year 10 to Year 5 6.07 (9.29, 2.85)* 6.57 (9.76, 3.37)* 5.32 (8.55, 2.10)* 5.95 (9.11, 2.80)*
Year 15 to Year 10 0.16 (3.50, 3.17) 1.23 (4.53, 2.07) 4.07 (0.81, 7.32)* 4.09 (0.91, 7.28)*
Year 20 to Year 15 4.89 (8.38, 1.40)* 4.49 (7.96, 1.03)* 3.84 (7.19, 0.50)* 2.08 (5.35, 1.19)
Year 25 to Year 20 4.79 (1.17, 8.42)* 4.54 (0.97, 8.11)* 5.21 (1.72, 8.71)* 3.70 (0.31, 7.09)*
BMI (≥30 vs <30 kg/m2) 7.65 (5.37, 9.92)* 4.98 (2.72, 7.25)*
Physical activity
(≥75th percentile vs
<75th percentile)†
0.86 (2.62, 0.91) 1.56 (3.24, 0.12)
Continued
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Triglyceride levels differed the most between sexes. As
observed in men, there were essentially ﬂat trends in black
women before or after adding modiﬁable risk factors to the
models; in white women, after year 5 (ages 23–35 years),
small, but statistically signiﬁcant, increases in triglycerides
relative to each previous time window were observed. This
trend in white women existed despite their lower mean BMI
relative to the other groups at every time point (ranging from
23.1 to 28.1 kg/m2 across time). Obesity again was asso-
ciated with the largest increases in triglycerides relative to
nonobese participants, accounting for 12.8- and 39.8-mg/dL
increases over 25 years in black women and white women,
respectively, after accounting for the time and aging trends.
Physical activity was also not associated with triglyceride
trends for white women, while statistically signiﬁcant for black
women.
Discussion
We have found that the initially favorable age-matched trends
in total cholesterol and LDL-c values from 1985 to 2011 have
slowed and show signs of leveling off or even worsening in a
cohort of young healthy adults initially free of cardiovascular
disease. These trends were largely unaffected by controlling
for modiﬁable lifestyle factors. Secular trends were similar for
blacks, whites, men, and women with the exception of black
women, whose favorable lipid levels did not yet appear to be
reversing. This is in contrast to results reported by Bild
et al.19 for the ﬁrst 7 years of follow-up in CARDIA that
showed more-pronounced favorable trends in the same
cohort.
Secular trends in HDL-c generally improved in the cohort
after a period of decline during early middle age, but
triglycerides exhibited unfavorable upward secular trends in
white women and relatively ﬂat trends for blacks and white
men between 1985 and 2011. Whereas modiﬁable lifestyle
factors, such as alcohol consumption, cigarette smoking, and
physical activity, were modestly associated with overall lipid
trends, increases in obesity prevalence adversely affected
lipid levels in all race-sex groups. The lack of confounding of
the age-matched time associations with lipids suggests that
other factors, such as physical activity and moderate alcohol
Table 2. Continued
Black Men/Model 1 Black Men/Model 2 White Men/Model 1 White Men/Model 2
Current vs never smokers 6.34 (9.03, 3.66)* 2.76 (0.30, 5.81)
Former vs never smokers 2.62 (5.70, 0.47) 1.95 (0.80, 4.69)
Alcohol (yes/no) 2.48 (0.68, 4.28)* 3.29 (1.52, 5.06)*
Antihyperlipidemic
medications (yes/no)
32.8 (36.8, 28.8)* 46.2 (49.2, 43.1)*
Triglycerides
CARDIA exams
Year 5 to Year 0 3.57 (1.97, 9.11) 2.07 (3.47, 7.61) 2.40 (7.00, 11.76) 0.46 (9.68, 8.75)
Year 10 to Year 5 6.84 (0.83, 12.84)* 6.21 (0.27, 12.15)* 7.77 (2.33, 17.88) 6.71 (3.28, 16.69)
Year 15 to Year 10 5.09 (1.16, 11.33) 3.51 (2.65, 9.67) 13.7 (3.46, 23.9)* 11.3 (1.23, 21.4)*
Year 20 to Year 15 0.03 (6.69, 6.63) 0.45 (7.06, 6.16) 0.70 (9.79, 11.19) 0.62 (11.04, 9.79)
Year 25 to Year 20 0.49 (6.53, 7.50) 0.29 (7.25, 6.66) 1.43 (9.61, 12.47) 1.39 (12.37, 9.60)
BMI (≥30 vs <30 kg/m2) 29.3 (24.7, 34.0)* 45.8 (38.2, 53.5)*
Physical activity
(≥75th percentile
vs <75th percentile)†
5.21 (9.01, 1.41)* 9.09 (14.81, 3.37)*
Current vs never smokers 6.16 (1.05, 11.27)* 12.1 (2.43, 21.86)*
Former vs never smokers 4.09 (2.20, 10.37) 10.6 (1.76, 19.42)*
Alcohol (yes/no) 2.25 (1.55, 6.05) 1.58 (4.42, 7.57)
Antihyperlipidemic
medications (yes/no)
5.10 (14.00, 3.81) 18.2 (29.1, 7.44)*
Model 1: adjusted for age, age2, center, and education. Model 2: model 1 plus the other variables listed. BMI indicates body mass index; CARDIA, Coronary Artery Risk Development in
Young Adults; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol.
*Statistically signiﬁcant at P<0.05.
†75th percentile of exercise is 620 exercise units in men.
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Table 3. Changes in Plasma Lipid Levels (in mg/dL) Among Women in 5-Year Intervals Over 25 Years of Follow-up, Adjusted for
Age, Education, and Clinic Site (Model 1) Plus Modiﬁable Lifestyle Factors (Model 2), by Race Group: the CARDIA Study, 1985–
2011
Black Women/Model 1 Black Women/Model 2 White Women/Model 1 White Women/Model 2
LDL-c
CARDIA exams
Year 5 to Year 0 7.66 (9.93, 5.40)* 7.87 (10.15, 5.59)* 4.29 (6.72, 1.85)* 4.83 (7.25, 2.41)*
Year 10 to Year 5 3.69 (6.06, 1.32)* 4.18 (6.53, 1.83)* 2.46 (4.94, 0.017) 3.10 (5.53, 0.67)*
Year 15 to Year 10 1.80 (4.24, 0.63) 2.32 (4.74, 0.099) 1.56 (4.07, 0.94) 2.70 (5.16, 0.24)*
Year 20 to Year 15 5.89 (8.36, 3.42)* 5.25 (7.71, 2.80)* 5.62 (8.20, 3.05)* 4.73 (7.25, 2.21)*
Year 25 to Year 20 4.53 (7.08, 1.97)* 3.18 (5.73, 0.64)* 0.39 (3.08, 2.31) 0.18 (2.82, 2.45)
BMI (≥30 vs <30 kg/m2) 7.24 (5.72, 8.76)* 9.61 (7.79, 11.44)*
Physical activity
(≥75th percentile
vs <75th percentile)†
1.24 (2.64, 0.17) 1.22 (2.45, 0.0044)
Current vs never smokers 0.46 (2.64, 1.72) 4.94 (2.63, 7.25)*
Former vs never smokers 0.10 (2.44, 2.25) 1.28 (0.69, 3.25)
Alcohol (yes/no) 3.10 (4.39, 1.81)* 2.58 (3.88, 1.28)*
Antihyperlipidemic
medications (yes/no)
28.5 (31.4, 25.4)* 37.2 (40.5, 33.8)*
HDL-c
CARDIA exams
Year 5 to Year 0 0.87 (0.17, 1.92) 1.34 (0.33, 2.35)* 0.65 (1.86, 0.55) 0.39 (0.75, 1.54)
Year 10 to Year 5 3.26 (4.29, 2.17)* 3.17 (4.19, 2.14)* 4.95 (6.17, 3.73)* 4.41 (5.57, 3.26)*
Year 15 to Year 10 0.39 (0.69, 1.48) 0.31 (0.74, 1.36) 0.83 (2.06, 0.40) 0.51 (1.68, 0.66)
Year 20 to Year 15 2.75 (1.65, 3.85)* 2.57 (1.50, 3.64)* 2.57 (1.30, 3.83)* 2.65 (1.46, 3.85)*
Year 25 to Year 20 3.27 (2.12, 4.41)* 2.97 (1.86, 4.09)* 2.12 (0.80, 3.43)* 2.39 (1.14, 3.64)*
BMI (≥30 vs <30 kg/m2) 6.83 (7.52, 6.14)* 8.44 (9.32, 7.56)*
Physical activity
(≥75th percentile
vs <75th percentile)†
1.13 (0.48, 1.77)* 1.55 (0.96, 2.14)*
Current vs never smokers 2.78 (3.75, 1.81)* 2.95 (4.06, 1.85)*
Former vs never smokers 0.59 (1.64, 0.46) 0.26 (1.20, 0.68)
Alcohol (yes/no) 3.25 (2.66, 3.84)* 3.44 (2.82, 4.06)*
Antihyperlipidemic
medications (yes/no)
0.35 (1.65, 0.95) 1.06 (2.64, 0.52)
Total cholesterol
CARDIA exams
Year 5 to Year 0 6.91 (9.36, 4.46)* 6.64 (9.13, 4.15)* 3.01 (5.67, 0.36)* 2.77 (5.43, 0.11)*
Year 10 to Year 5 6.62 (9.19, 4.04)* 6.93 (9.52, 4.35)* 4.46 (7.17, 1.75)* 5.03 (7.71, 2.36)*
Year 15 to Year 10 0.96 (3.60, 1.69) 1.51 (4.17, 1.15) 0.44 (2.30, 3.19) 0.94 (3.66, 1.77)
Year 20 to Year 15 3.74 (6.42, 1.05)* 3.26 (5.95, 0.56)* 1.84 (4.67, 0.98) 0.87 (3.66, 1.92)
Year 25 to Year 20 1.66 (4.44, 1.12) 0.51 (3.31, 2.30) 3.19 (0.23, 6.16)* 3.18 (0.26, 6.10)*
BMI (≥30 vs <30 kg/m2) 2.84 (1.15, 4.52)* 8.43 (6.36, 10.50)*
Continued
DOI: 10.1161/JAHA.116.003384 Journal of the American Heart Association 8
25-Year Secular Trends in Lipids: The CARDIA Study Schreiner et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
 at U
N
IV
 O
F M
A
SSA
CH
U
SETTS on A
ugust 17, 2016
http://jaha.ahajournals.org/
D
ow
nloaded from
 
consumption, may counterbalance adverse associations with
obesity.
Much of the information available for population trends in
lipids comes from studies comprised of serial cross-sectional
data. In particular, NHANES has reported trends in serum
lipids from 1960 through 2010 in different waves and in
various age strata. The earliest evidence of a declining trend
in total cholesterol was presented for 3 time windows (1960–
1962, 1971–1974, and 1976–1980) among men and women
ages 20 to 74 years, with declines in both men and women,
and in whites, but not in blacks.20 Carroll et al.5 extended
these data to 2 additional waves through 2002, and reported
that the decline in total cholesterol continued and was
comparable for LDL-c. They attributed the trends to the
increasing prevalence of individuals using lipid-lowering
medications among the older age group, but suggested that
the increases in mean serum triglycerides observed were
related to increases in the prevalence of obesity. Carroll
et al.6 also examined the 2007–2010 age-adjusted NHANES
data among adults not using lipid-lowering medications, and
reported that the improved secular trends in lipids they
observed earlier persisted through 2010. Reasons for the
discrepancies between NHANES and CARDIA may include the
CARDIA cohort’s longitudinal data rather than serial cross-
sectional data in NHANES and CARDIA’s ability to adjust for
multiple demographic and modiﬁable risk factors.
Winkleby et al.21 found that trends for non-HDL-c and BMI
in women surveyed between 1988 and 1994 were less
favorable in those of lower educational attainment, and that
these trends tracked with physical inactivity and cigarette
smoking in Mexican-American and black women. The decline
in the proportion of high total cholesterol (≥240 mg/dL)
among those surveyed in NHANES was observed in all BMI
groups from 1976 to 2000.22 Taken together, these results
mirror our results of a decline in total and LDL-c through the
late 1990s with an increase in HDL-c, and that education,
race, smoking, and physical inactivity were important inde-
pendent contributors.
Table 3. Continued
Black Women/Model 1 Black Women/Model 2 White Women/Model 1 White Women/Model 2
Physical activity
(≥75th percentile
vs <75th percentile)†
0.91 (2.48, 0.65) 0.52 (0.88, 1.92)
Current vs never smokers 1.11 (3.51, 1.29) 4.06 (1.48, 6.64)*
Former vs never smokers 0.11 (2.47, 2.70) 1.13 (1.07, 3.33)
Alcohol (yes/no) 0.53 (0.91, 1.96) 0.73 (0.75, 2.20)
Antihyperlipidemic
medications (yes/no)
28.2 (31.5, 25.0)* 36.6 (40.4, 32.9)*
Triglycerides
CARDIA exams
Year 5 to Year 0 3.17 (6.78, 0.45) 2.79 (6.38, 0.79) 6.30 (1.43, 11.16)* 4.79 (0.081, 9.49)*
Year 10 to Year 5 1.55 (2.66, 5.77) 2.49 (1.72, 6.69) 12.5 (7.57, 17.5)* 10.1 (5.36, 14.8)*
Year 15 to Year 10 2.88 (1.46, 7.23) 3.49 (0.86, 7.84) 12.1 (7.04, 17.1)* 9.42 (4.63, 14.20)*
Year 20 to Year 15 0.52 (4.97, 3.93) 0.16 (4.63, 4.31) 5.19 (0.0071, 10.36)* 5.24 (0.29, 10.20)*
Year 25 to Year 20 2.69 (7.35, 1.96) 2.18 (6.90, 2.54) 5.62 (0.15, 11.09)* 3.17 (2.08, 8.43)
BMI (≥30 vs <30 kg/m2) 12.8 (9.92, 15.6)* 39.8 (35.9, 43.7)*
Physical activity
(≥75th percentile
vs <75th percentile)†
5.43 (8.06, 2.81)* 0.88 (1.84, 3.60)
Current vs never smokers 12.4 (8.61, 16.1)* 12.3 (7.69, 17.0)*
Former vs never smokers 5.62 (1.34, 9.90)* 1.27 (2.72, 5.25)
Alcohol (yes/no) 3.32 (0.90, 5.73)* 1.58 (4.41, 1.25)
Antihyperlipidemic medications (yes/no) 3.45 (2.80, 9.71) 5.94 (1.42, 13.30)
Model 1: adjusted for age, age2, center, and education. Model 2: model 1 plus the other variables listed. BMI indicates body mass index; CARDIA, Coronary Artery Risk Development in
Young Adults; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol.
*Statistically signiﬁcant at P<0.05.
†
75th percentile of exercise is 416 exercise units in women.
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Other US surveys, such as the Minnesota Heart Survey
(MHS), showed similar declines in total cholesterol levels and
increases in BMI as NHANES despite lower mean values of
these risk factors, but unlike NHANES and our data in
CARDIA, HDL-c remained constant between 1980 and
2002.9,23 The authors attributed these differences to the
lower proportion of people in MHS with elevated risk factors,
such as smoking, hypertension, and obesity, in agreement
with our ﬁndings that these risk factors are associated with
lipid values. The Pawtucket Heart Health Program observed a
similar decline in HDL-c as in NHANES and our data through
year 15, suggesting that the declines may be linked to a
speciﬁc period of time.24
Surveys in adults from different countries, such as Spain,
France, Finland, and Australia, all showed similar downward
secular trends in total cholesterol and/or LDL-c,25–28
although these serial cross-sectional surveys also reported
declines in HDL-c and increases in triglycerides during the
same time periods as our study. In contrast, surveys in
countries such as Japan7 and India8 showed age-adjusted
increases in secular trends for both mean total cholesterol
and triglycerides in the same time period despite increases in
lipid-lowering medication use, with increasing trends in total
cholesterol and decreasing trends in HDL-c also observed in a
Japanese longitudinal cohort study.29 These data may point to
populations that are at different stages of risk factor
transition.
Limitations of the present study include the lack of dietary
data at some time points. However, when we controlled for
caloric intake and saturated fat using data from the year 0
exam, we observed no impact on the secular trends. Data
from NHANES suggest that US diets have shown increases in
mean energy intake, larger portion sizes, increased consump-
tion of sweetened beverages, and more late-night snacking
during the time period of our data collection. Though the
percentage of energy from fat decreased, this was driven by
increases in carbohydrates ad calories rather than an absolute
reduction in fat intake.30,31 For the sake of analytic simplicity,
we chose to examine lipid trends in equal 5-year intervals
rather than all time points. Though the age ranges across all
25 years do not completely overlap, sensitivity analyses
showed little difference when limited to subsamples with
overlapping age ranges longitudinally. In addition, because of
the relatively narrow age range of the CARDIA participants,
the birth cohort effect is likely to be minimal.18
The ﬁndings of our study are unique in capturing secular
trends in a large biracial cohort of individuals followed
longitudinally over time using standardized data collection and
assays. The data also were collected in an age range when
antihyperlipidemic medication use was relatively low, ranging
from 0% at baseline to 15% to 20% by year 25, and may
indicate that the improvements we observed in atherogenic
lipids have diminished as the obesity epidemic continues and
physical inactivity becomes more common, but that greater
medication use could lead to the more-favorable trends
previously observed.
Ford et al.32 showed that in US adults 25 to 84 years
observed from 1980 to 2000, deaths from coronary heart
disease fell from 542.9 to 266.8 cases per 100 000 in men
and from 263.3 to 134.4 per 100 000 in women. They
estimated that half of this decline was linked to evidence-
based medical therapies, such as medications and proce-
dures, and the other half was linked to improvements in
modiﬁable risk factors.
In conclusion, initially favorable secular trends in total
cholesterol and LDL-c have leveled off and may be reversing,
and were not markedly changed after controlling for modiﬁ-
able lifestyle factors. Though we were not able to identify the
cause of unfavorable secular trends in these observational
data, factors such as dietary changes over 25 years and
perhaps poor adherence to medications are candidates for
additional investigation.
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